PerkinElmer PKI Stock
PerkinElmer Price Chart
PerkinElmer PKI Financial and Trading Overview
PerkinElmer stock price | 131.52 USD |
Previous Close | 116.3 USD |
Open | 115.98 USD |
Bid | 0 USD x 800 |
Ask | 0 USD x 1100 |
Day's Range | 114.67 - 117.21 USD |
52 Week Range | 113.17 - 170 USD |
Volume | 1.63M USD |
Avg. Volume | 808.39K USD |
Market Cap | 14.46B USD |
Beta (5Y Monthly) | 1.101337 |
PE Ratio (TTM) | 41.453236 |
EPS (TTM) | 0 USD |
Forward Dividend & Yield | 0.28 (0.23%) |
Ex-Dividend Date | July 20, 2023 |
1y Target Est | 149.71 USD |
PKI Valuation Measures
Enterprise Value | 18.58B USD |
Trailing P/E | 41.453236 |
Forward P/E | 19.834768 |
PEG Ratio (5 yr expected) | -8.28 |
Price/Sales (ttm) | 4.3649144 |
Price/Book (mrq) | 1.9714309 |
Enterprise Value/Revenue | 5.61 |
Enterprise Value/EBITDA | 14.44 |
Trading Information
PerkinElmer Stock Price History
Beta (5Y Monthly) | 1.101337 |
52-Week Change | -25.29% |
S&P500 52-Week Change | 20.43% |
52 Week High | 170 USD |
52 Week Low | 113.17 USD |
50-Day Moving Average | 127.44 USD |
200-Day Moving Average | 131.99 USD |
PKI Share Statistics
Avg. Volume (3 month) | 808.39K USD |
Avg. Daily Volume (10-Days) | 933.54K USD |
Shares Outstanding | 125.44M |
Float | 116.15M |
Short Ratio | 5.07 |
% Held by Insiders | 0.26% |
% Held by Institutions | 86.25% |
Shares Short | 3.53M |
Short % of Float | 3.57% |
Short % of Shares Outstanding | 2.79% |
Dividends & Splits
Trailing Annual Dividend Rate | 0.28 |
Trailing Annual Dividend Yield | 0.24% |
5 Year Average Dividend Yield | 25.00% |
Payout Ratio | 0.1 |
Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | January 1, 2023 |
Most Recent Quarter (mrq) | January 1, 2023 |
Next Fiscal Year End | January 1, 2024 |
Profitability
Profit Margin | 17.18% |
Operating Margin (ttm) | 25.95% |
Gross Margin | 61.61% |
EBITDA Margin | 38.84% |
Management Effectiveness
Return on Assets (ttm) | 3.68% |
Return on Equity (ttm) | 7.05% |
Income Statement
Revenue (ttm) | 3.31B USD |
Revenue Per Share (ttm) | 26.25 USD |
Quarterly Revenue Growth (yoy) | -27.90% |
Gross Profit (ttm) | 2.04B USD |
EBITDA | 1.29B USD |
Net Income Avi to Common (ttm) | 512.68M USD |
Diluted EPS (ttm) | 2.78 |
Quarterly Earnings Growth (yoy) | -32.89% |
Balance Sheet
Total Cash (mrq) | 454.36M USD |
Total Cash Per Share (mrq) | 3.59 USD |
Total Debt (mrq) | 4.6B USD |
Total Debt/Equity (mrq) | 62.25 USD |
Current Ratio (mrq) | 2.129 |
Book Value Per Share (mrq) | 58.455 |
Cash Flow Statement
Operating Cash Flow (ttm) | 679.81M USD |
Levered Free Cash Flow (ttm) | -262123008 USD |
Profile of PerkinElmer
Country | United States |
State | MA |
City | Waltham |
Address | 940 Winter Street |
ZIP | 02451 |
Phone | 781 663 6900 |
Website | https://www.perkinelmer.com |
Industry | Diagnostics & Research |
Sector(s) | Healthcare |
Full Time Employees | 16700 |
Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection, and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
Q&A For PerkinElmer Stock
What is a current PKI stock price?
PerkinElmer PKI stock price today per share is 131.52 USD.
How to purchase PerkinElmer stock?
You can buy PKI shares on the NYSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for PerkinElmer?
The stock symbol or ticker of PerkinElmer is PKI.
Which industry does the PerkinElmer company belong to?
The PerkinElmer industry is Diagnostics & Research.
How many shares does PerkinElmer have in circulation?
The max supply of PerkinElmer shares is 126.41M.
What is PerkinElmer Price to Earnings Ratio (PE Ratio)?
PerkinElmer PE Ratio is 0.00000000 now.
What was PerkinElmer earnings per share over the trailing 12 months (TTM)?
PerkinElmer EPS is 0 USD over the trailing 12 months.
Which sector does the PerkinElmer company belong to?
The PerkinElmer sector is Healthcare.
PerkinElmer PKI included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG | 2541.54 USD — |
-1.89
|
— — | 2531.95 USD — | 2572.66 USD — | — - | — — |
NASDAQ DM Ind Goods & Svcs Lg M NQDM2700LMT | 1757.5 USD — |
<0.01
|
— — | 1752.33 USD — | 1774.66 USD — | — - | — — |
NASDAQ N America Inds Large Mid NQNA2000LMCADN | 2303.44 CAD 1709.29 USD |
<0.01
|
— — | 2303.44 CAD 1709.29 USD | 2303.44 CAD 1709.29 USD | — - | — — |
NASDAQ DM Ex Japan Large Mid Ca NQDMXJPLMAUD | 2100.38 AUD 1390.15 USD |
<0.01
|
— — | 2100.38 AUD 1390.15 USD | 2100.38 AUD 1390.15 USD | — - | — — |
NASDAQ DM Ind Goods & Svcs Lg M NQDM2700LMJPYT | 1761.11 JPY 11.89 USD |
<0.01
|
— — | 1761.11 JPY 11.89 USD | 1761.11 JPY 11.89 USD | — - | — — |
NYSE COMPOSITE (DJ) NYA | 17639.04 USD — |
-1.54
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}